Long Hill Capital has reached a USD300m final close for its third fund, a vehicle targeting early-stage investments in the healthcare and longevity sectors in China. Read more… Read More
Falcon Edge Capital, Goldman Sachs, Think Capital, Amansa Capital and Carmignac have invested USD800m in India-based food delivery platform Swiggy, with follow-on from Prosus Ventures and Accel, at a reported USD5b valuation. Read more… Read More
EverSource Capital, through its subsidiary Radiance Renewables, has acquired solar rooftop assets with a 152MW capacity in India from Azure Power Global for INR5.36b (~USD73m). Read more… Read More
SoftBank Vision Fund 2 led a USD300m Series E for India-based social e-commerce company Meesho, with participation from Facebook, Prosus Ventures, Shunwei Capital, Venture Highway and Knollwood Investment, at a reported USD2.1b valuation. Read more… Read More
B Capital has reached a USD415m final close for Elevate, a fund that will provide follow-on capital to later-stage companies within B Capital’s portfolio. Read more… Read More
FMO has agreed to invest USD137m in Green Growth Equity Fund (GGEF), a vehicle managed by EverSource Capital. The fund will invest in clean energy, transportation, resource efficiency and energy services in India. Read more… Read More
Hillhouse Capital, Boyu Capital and Sequoia Capital China have invested a USD2b+ round for Indonesia-based logistics and courier service J&T Express. Read more… Read More
TPG Growth, ChrysCapital and Premji Invest have invested USD315m in India-based baby product retailer FirstCry at a reported valuation of USD1.9-2.1m, facilitating an exit for Elevation Capital, Vertex Partners and MegaDelta Capital Advisors. Read more… Read More
Sorenson Capital Partners led a USD140m Series D for Uniphore Software, an India-based customer service analytics platform, with participation from Cisco Investments and follow-on from Chiratae Ventures and March Capital Partners. Read more… Read More
Morgan Stanley Private Equity Asia and Sichuan Pharmaceuticals have agreed to sell their 80% stake in China-based Huaiyin Hospital for CNY882.8m (~USD134.3m). Read more… Read More
(default archive template)